Abstract
AbstractSeveral 3‐alkoxysubstituted pyrazolo[3,4‐d]pyrimidine ribonucleosides structurally related to adenosine, inosine and guanosine have been prepared by the direct glycosylation of preformed aglycon precursor containing a 3‐alkoxy substituent. Ring closure of 5(3)‐amino‐3(5)‐ethoxypyrazole‐4‐carboxamide (6b) with either formamide or potassium ethyl xanthate gave 3‐ethoxyallopurinol (7b) and 3‐ethoxy‐6‐thioxopyrazolo[3,4‐d]‐pyrimidin‐4(5H,7H)‐one (10), respectively. Methylation of 10 gave the corresponding 6‐methylthio derivative 15. Similar ring annulation of 5(3)‐methoxypyrazole‐4‐carboxamide (6a) with formamide afforded 3‐methoxyallopurinol (7a). Treatment of 5(3)‐amino‐3(5)‐methoxypyrazole‐4‐carbonitrile (5a) with formamidine acetate furnished 4‐amino‐3‐methoxypyrazolo[3,4‐d]pyrimidine (4). High‐temperature glycosylation of 7b with 1‐O‐acetyl‐2,3,5‐tri‐O‐benzoyl‐D‐ribofuranose in the presence of boron trifluoride etherate gave a 2:1 mixture of N‐1 and N‐2 glycosyl blocked nucleosides 11b and 13b. Deprotection of 11b and 13b with sodium methoxide gave 3‐ethoxy‐1‐β‐D‐ribofuranosylpyrazolo[3,4‐d]pyrimidin‐4(5H)‐one (12b) and the corresponding N‐2 glycosyl isomer 14b, respectively. Similar glycosylation of either 4 or 7a, and subsequent debenzoylation gave exclusively 4‐amino‐3‐methoxy‐1‐β‐D‐ribofuranosylpyrazolo[3,4‐d]pyrimidine (9) and 3‐methoxy‐1‐β‐D‐ribofuranosylpyrazolo[3,4‐d]pyrimidin‐4‐(5H)‐one (12a), respectively. The structural assignment of 12a was made on the basis of single‐crystal X‐ray analysis. Application of this general glycosylation procedure to 15 gave the corresponding N‐1 glycosyl derivative 16 as the sole product, which on debenzoylation afforded 3‐ethoxy‐6‐(methylthio)‐1‐(3‐D‐ribofuranosylpyrazolo[3,4‐d]pyrimidin‐4(5H)‐one (17). Oxidation of 16 and subsequent ammonolysis furnished the guanosine analog 6‐arnino‐3‐ethoxy‐1‐β‐D‐ribofuranosylpyrazolo[3,4‐d]‐pyrimidin‐4(5H)‐one (19). Similarly, starting from 3‐methoxy‐4,6‐bis(methylthio)pyrazolo[3,4‐d]pyrimidine (20), 6‐amino‐3‐methoxy‐1‐β‐D‐ribofuranosylpyrazolo[3,4‐d]pyrimidin‐4(5H)‐one (23) was prepared.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.